Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Covis Pharma initiates phase III study of Alvesco inhaler for the treatment of COVID-19

May 20, 2020

New in vivo data support prophylactic treatment potential of brilacidin against COVID-19

May 20, 2020

Phase II study of MGB-BP-3 in CDI meets primary endpoints

May 20, 2020

Sorrento's STI-1499 demonstrates 100% inhibition of SARS-CoV-2 virus infection in vivo

May 19, 2020

New adjuvant reverses MDR in Gram-negatives

May 19, 2020

Intermediary results presented for VLP COVID-19 vaccine in mice

May 19, 2020

FDA clears IND application for phase II study of merimepodib in advanced COVID-19

May 19, 2020

Interim phase I data presented for mRNA-1273 coronavirus vaccine

May 19, 2020

CureVac announces positive preclinical data for its coronavirus vaccine candidate

May 18, 2020

VSY Biotechnology developing TR-C 19 to treat COVID-19

May 18, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...